Diabetes drugs lower heart disease risk, raise gastro, arthritic disorders, study suggests
New Delhi, January 20, 2025.
Commonly used diabetes drugs could lower the risk of cardiometabolic conditions but heighten the risk of gastrointestinal and arthritic ones, hypotension, among others, according to a study.
Researchers from Washington University in St. Louis analysed data from the US Department of Veterans Affairs to examine links between taking 'GLP-1RA' drugs and 175 health outcomes. Data from 2.4 million participants with diabetes were analysed.
GLP-1RA, or glucagon-like peptide 1 receptor agonists, are drugs that work by mimicking the action of the hormone GLP-1 that helps control blood sugar and promote feelings of satiety. Through weight management, the drugs can also treat type 2 diabetes.